Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
China · Delayed Price · Currency is CNY 9.58
+0.05 (0.52%)
Sep 14, 2026, 11:29 AM CST
Shenzhen YHLO Biotech Revenue
Shenzhen YHLO Biotech had revenue of 490.14M CNY in the quarter ending June 30, 2026, with 25.47% growth. This brings the company's revenue in the last twelve months to 1.89B, up 1.62% year-over-year. In the year 2025, Shenzhen YHLO Biotech had annual revenue of 1.81B, down -9.99%.
Revenue (ttm)
1.89B
Revenue Growth
+1.62%
P/S Ratio
2.88
Revenue / Employee
1.14M
Employees
1,664
Market Cap
5.45B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.81B | -200.99M | -9.99% |
| Dec 31, 2024 | 2.01B | -41.48M | -2.02% |
| Dec 31, 2023 | 2.05B | -1.93B | -48.42% |
| Dec 31, 2022 | 3.98B | 2.80B | 237.95% |
| Dec 31, 2021 | 1.18B | 178.89M | 17.91% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Huakang Century Clean Technology | 2.47B |
| Edan Instruments | 2.11B |
| BMC Medical | 1.38B |
| Shenzhen Lifotronic Technology | 1.13B |
| Getein Biotech | 1.09B |
| Xiangyu Medical Co.,Ltd | 781.87M |
| Shanghai Kinetic Medical | 777.21M |
| Hangzhou AGS MedTech | 592.88M |
Shenzhen YHLO Biotech News
- 18 days ago - Shenzhen YHLO Biotech Quarterly report: Q2 2026 - Filings
- 4 months ago - Shenzhen YHLO Biotech Annual report: H2 2025 - Filings
- 4 months ago - Shenzhen YHLO Biotech Quarterly report: Q1 2026 - Filings
- 10 months ago - Shenzhen YHLO Biotech Quarterly report: Q3 2025 - Filings